Skip to primary navigation Skip to main content
Buffalo Local Index
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Local Stocks
Gilead Sciences (NQ: GILD)
73.27 USD  -0.90 (-1.21%)
Official Closing Price  /  Updated: 6:42 PM EDT, Oct 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 5,036,400
Open 74.15
Bid (Size) 73.10 (1)
Ask (Size) 73.74 (1)
Prev. Close 74.17
Today's Range 73.15 - 74.80
52wk Range 64.27 - 89.54
Shares Outstanding 1,300,260,832
Dividend Yield 2.98%
Performance
YTD
-1.12%
-1.12%
1 Month
-0.83%
-0.83%
3 Month
-5.30%
-5.30%
6 Month
-0.58%
-0.58%
1 Year
-10.20%
-10.20%
Top News
More News
These 2 Biotechs Poised To Top Quarterly Views Amid Slowdown
Gilead Sciences and Amgen are poised to top third-quarter views, but biotech companies will broadly face sequential declines on currency headwinds, an analyst predicted Monday. Read More
from Investor's Business Daily
Gilead Sciences to Release Third Quarter 2018 Financial Results on Thursday, October 25, 2018
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2018 financial results will be released on Thursday, October 25, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s... Read More
from Business Wire News Releases
More News
Read More
Gilead to Present Wide-Ranging New Data on Treatment and Diagnosis of Liver Diseases at The Liver Meeting® 2018
from Business Wire News Releases
Amid Broader Downturn, These 3 Biotech Stocks Look 'Compelling'
from Investor's Business Daily
REFILE-Drop in Australia HIV sparks call for greater drug roll-out
category companyNews
from Reuters: Company News
Cramer's lightning round: For growth and yield, go with Verizon over Kraft Heinz
category Crane Co , Verizon Communications Inc , Crane Company , and 19 more.
from CNBC.com News
Drop in Australia HIV sparks call for greater drug roll-out
category companyNews
from Reuters: Company News
Can UnitedHealth Group and Johnson & Johnson Continue Their Winning Ways?
category UNH , GILD , Market News , and 1 more.
from Motley Fool
Notable Tuesday Option Activity: GS, CMG, GILD
category Stocks
from Market News Video
Is Sangamo Therapeutics Inc. a Buy?
category SNY , PFE , Market News , and 2 more.
from Motley Fool
NetworkNewsAudio – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Developing Personalized Immunotherapies for Advanced Breast Cancer Treatment
from NetworkNewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.